Amgen completes acquisition of Horizon Therapeutics.
Amgen today announced that it has completed its acquisition of Horizon plc for $116.50 per share in cash, representing a transaction equity value of approximately $27.8 billion. “Today marks an exciting milestone as we welcome Horizon employees to Amgen and…
